悦安欣、神经生长因子治疗糖尿病神经系统病变的疗效观察
被引量:1
摘要
近年来我院采用悦安欣、神经生长因子治疗糖尿病神经系统病变50例,疗效可靠,现报道如下.
出处
《河南实用神经疾病杂志》
2004年第3期71-72,共2页
Henan Journal of Practical Nervous Diseases
同被引文献7
-
1[1]付小兵主编.生长因子与创伤修复[M].北京:人民军医出版社,1991.161~166
-
2[2]Brewster WJ,Fernyhough P,Diemel LT,et al.Diabetic neuropathy,nerve growth factor and other neurotrophic factors[J].Trends Neurosci,1994,17(8):321~325
-
3[3]Goss JR,Goins WT,Lacomis D,et al.Herpes simplex-mediated gene transfer of nerve growth factorprotects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse[J].Diabetes,2002,51(7):2227~2232
-
4[5]Trupp M,Belluarod N,Funakoshi H.Complementary and overlapping expression.of glial cell line-derived neu-rotrophic factor (GDNF),c-repproto-oncogene,and GDNF recetoralpha indicates multiple mechanisms of trophic actions in the adult rat CNS[J].J Neurosci,1997,17(10):3554~3562
-
5[6]Ebadi M,Bashir RM,Heidrick ML,et al.Neurotrophins and their receptors in nerve injury and repair[J].Neurochem Int,1997,30(45):347~374
-
6[8]Burazin TC,Gundlach AL.Up-regulation of GDNFR alpha and cret mRNA in facial motorneurons following facial nerve injury in the rat[J].Brain Res Mol Brain Res,1998,55(2):331~336
-
7陈哲宇,曹莉,路长林,何成,鲍璿.周围神经损伤后外源性GDNF对神经元的保护作用[J].生理学报,2000,52(4):295-300. 被引量:13
-
1王明芳.悦安欣和硫酸镁联用治疗冠心病心绞痛120例[J].临床医学,2002,22(7):22-23.
-
2刘勇,安良,屈金刚.苦碟子治疗不稳定型心绞痛的临床观察[J].中原医刊,2004,31(13):36-36. 被引量:6
-
3陆玉丽,何孟国,任南沙.悦安欣联合酚妥拉明治疗慢性肺源性心脏病临床观察[J].中西医结合心脑血管病杂志,2005,3(5):443-444.
-
4徐莉华,王翠梅,李铭,杨国庆.悦安欣对急性心肌梗死再灌注时心肌顿抑的影响[J].山西医药杂志,2005,34(3):230-231.
-
5杜凤芝,杨金凤,李云龙.悦安欣注射液治疗心绞痛疗效观察[J].现代中西医结合杂志,2010,19(33):4289-4290.
-
6胡良建,陈向红.糖尿病并发神经系统病变16例分析[J].临床医学,2003,23(11):36-36.
-
7贾永军,刘清芳.弥可保联用银杏达莫治疗糖尿病神经系统病变的疗效观察[J].中国现代医药杂志,2006,8(7):104-104.
-
8范金涛.苦碟子注射液治疗不稳定性心绞痛临床观察[J].职业与健康,2010,26(12):1423-1424. 被引量:2
-
9彭立文,王子焕.悦安欣注射液治疗慢性肺心病急性发作期64例临床观察[J].中国中医急症,2005,14(8):715-715.
-
10黄国平,朱庆.灯盏花素、弥可保治疗糖尿病神经系统病变的疗效观察[J].实用中西医结合临床,2006,6(1):61-61.